Bausch Health Companies (BHC) PT Lowered to $37 at Piper Sandler on Weak Guidance
Tweet Send to a Friend
Piper Sandler analyst David Amsellem lowered the price target on Bausch Health Companies (NYSE: BHC) to $37.00 (from $39.00) after ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
